Exploring the Role of JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis

PROGRAM OVERVIEW

This enduring activity will cover the care and treatment of patients with moderate-to-severe atopic dermatitis.


TARGET AUDIENCE

This enduring activity is intended for dermatologists, allergists, advanced practitioners, and other health care professionals involved in the care and treatment of patients with moderate-to-severe atopic dermatitis.


LEARNING OBJECTIVES

On completing the program, attendees should be able to:

  • Identify patients with moderate-to-severe atopic dermatitis (AD) who may benefit from systemic therapy
  • Evaluate clinical trial data on the efficacy and safety of available and emerging JAK inhibitors for treating AD
  • Develop individualized treatment plans for adolescent and adult patients with AD who require treatment intensification
  • Recognize and manage adverse events associated with JAK inhibitors in managing AD

ACCREDITATION AND DESIGNATION STATEMENTS

PHYSICIAN
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES
This program would be beneficial for nurses involved in treating and managing patients with moderate-to-severe atopic dermatitis.

CNE Credits:
1.0 ANCC Contact Hour

Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.


FACULTY


Peter Lio, MD (Program Chair)
Clinical Assistant Professor of Dermatology and Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, Illinois


DISCLOSURE OF UNLABELED USE

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.


DISCLOSURE OF FINANCIAL RELATIONSHIPS

SPEAKER RELATIONSHIP MANUFACTURER
Peter A. Lio, MD
(Program Chair)
Consultant Dermavant Sciences, Galderma, Pierre-Fabre, Level Ex, UCB, Regeneron/Sanofi Genzyme, Pfizer, Micreos, Johnson and Johnson, Menlo Therapeutics, IntraDerm, AOBiome, Realm Therapeutics, Altus Labs, Verrica, Arbonne, Bodewell, YobeeCare, My-Or Diagnostics, Kimberly-Clark
Speaker Unilever, Arbonne, Verrica, Burt’s Bees, Galderma, Eli Lilly and Company, L’Oreal USA Inc.
Advisory Board Dermira, Pfizer, LEO Pharmaceuticals, AbbVie, Eli Lilly and Company, L’Oreal USA Inc., Pierre-Fabre, Level Ex, Unilever, Theraplex, Exeltis, AOBiome, Galderma, Amyris, Bodewell, YobeeCare, Burt’s Bees, My-Or Diagnostics, and Kimberly-Clark
Research National Eczema Association, AOBiome, Regeneron/Sanofi Genzyme, AbbVie
Patent Holder Theraplex
Stockholder Micreos, YobeeCare, and Altus Labs

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

Planners
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Marcello Morgan, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing
Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing
Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.


DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.


METHOD OF PARTICIPATION

There are no fees for participating in and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Complete pre and post survey.
  4. Submit the evaluation form online.

You will receive your certificate as a downloadable file.


DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. Participants should use their clinical judgment, knowledge, experience, and diagnostic decision-making experience before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

RELEASE DATE: September 21, 2021

EXPIRATION DATE: September 21, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITY ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at info@medlearninggroup.com

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.